Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000912057-02-036654
Filing Date
2002-09-23
Accepted
2002-09-23 15:05:48
Documents
5
Effectiveness Date
2002-09-23

Document Format Files

Seq Description Document Type Size
1 S-8 a2089524zs-8.htm S-8 29525
3 EX-4.1 a2089524zex-4_1.htm EX-4.1 36241
4 EX-4.2 a2089524zex-4_2.htm EX-4.2 42362
5 EX-5.0 a2089524zex-5_0.htm EX-5.0 3513
6 EX-23.2 a2089524zex-23_2.htm EX-23.2 2357
  Complete submission text file 0000912057-02-036654.txt   115983
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-100011 | Film No.: 02769955
SIC: 2836 Biological Products, (No Diagnostic Substances)